The company’s product portfolio is anchored by Eylea, used in treating various eye diseases ... Should you invest in REGN right now? Consider this first: Investing.com’s ProPicks, an AI ...

The company’s product portfolio is anchored by Eylea, used in treating various eye diseases, and Dupixent ... Should you invest in REGN right now? Consider this first: Investing.com’s ProPicks, an ...

Earlier this year, biotech company 23andMe filed for bankruptcy. The harsh reality was that its business, while enticing to people who wanted to learn about their backgrounds via DNA testing kits, ...

US President Donald Trump’s tariff hammer against the European Union caused stock markets to falter at the close of the ...

German drugmaker Bayer on Friday won an endorsement by the European Medicines Agency to extend the intervals between shots of ...

The company’s product portfolio is anchored by Eylea, used in treating various eye diseases, and Dupixent, which has shown significant growth potential across multiple indications. In the first ...

plus a reduced need for injections into the eye with current therapy Eylea. On the strength of the results, 4DMT is planning to start a phase 3 trial of the gene therapy by the end of the first ...

found to be roughly equivalent to Bayer and Regeneron's Eylea (aflibercept) when it came to inflammatory reactions in the eye. Earlier this year, Novartis halted three trials of Beovu in wet age ...

Sometimes I would use just one eye to look at an area before I headed ... There was a black patch right in the centre of my sight and I was told I needed an operation.” He decided to shut ...